Prerecorded Webinar: The ABCs of IBS

Pharmacy Tech CEU
notesPre-Recorded
Contact Hours: 1.0 (0.1 CEUs)

Course Summary

Irritable bowel syndrome, or IBS, is a challenging gastrointestinal disorder that not only causes abdominal pain but often leads to decreased mental health, well-being, and quality of life for patients. The pathophysiology and treatment strategies associated with IBS are complex, and its management requires a multidisciplinary approach centered on the predominant symptoms of patients. This continuing education program will discuss the pathological processes involved in the development of IBS, the approach to diagnosis, and treatment strategies. Nonpharmacologic and pharmacologic approaches will be explored with a focus on emerging treatment strategies.


Course Objectives

Describe the pathophysiology of irritable bowel syndrome (IBS)

Differentiate the types of IBS based on presenting symptoms

Identify nonpharmacologic strategies for the management of IBS

Compare and contrast pharmacologic agents used in the management of IBS


I. Introduction

II. Epidemiology

III. Pathophysiology

IV. Clinical Presentation and Diagnosis

V. Approaches to IBS Management

A. Lifestyle Interventions
B. Pharmacologic Treatment Strategies
C. Treatment of IBS-C
D. Treatment of IBS-D
E. Adjunct Agents

VI. Tips and Considerations for Pharmacy Technicians

VII. Clinical Pearls and Additional Resources Summary

VIII. Summary

How to Earn Credit:
To earn credit for this course, participants must:
  1. Read the course objectives and faculty planner disclosure
  2. Read the course material
  3. Complete the post-test with a minimum score of 70% and complete the course evaluation form.
  4. Results are automatically submitted to CPE Monitor

Faculty Planner Disclosure

The following individuals were involved in the development of this activity: L. Austin Fredrickson, MD, FACP, and Pamela Sardo, PharmD, BS. Pamela Sardo was an employee of Rhythm Pharmaceuticals until March 2022 and has no conflicts of interest or relationships regarding the subject matter discussed. There are no financial relationships or commercial or financial support relevant to this activity to report or disclose by RxCe.com or any of the individuals involved in the development of this activity.


Unlabeled Use Disclosures

The information provided in this course is general in nature and it is solely designed to provide participants with continuing education credit(s). This course and materials are not meant to substitute for the independent, professional judgment of any participant regarding that participant’s professional practice, including but not limited to patient assessment, diagnosis, treatment and/or health management. Medical and pharmacy practices, rules, and laws vary from state to state, and this course does not cover the laws of each state; therefore, participants must consult the laws of their state as they relate to their professional practice. Healthcare professionals, including pharmacists and pharmacy technicians, must consult with their employer, healthcare facility, hospital, or other organization, for guidelines, protocols, and procedures they are to follow. The information provided in this course does not replace those guidelines, protocols, and procedures but is for academic purposes only, and this course’s limited purpose is for the completion of continuing education credits. Participants are advised and acknowledge that information related to medications, their administration, dosing, contraindications, adverse reactions, interactions, warnings, precautions, or accepted uses are constantly changing, and any person taking this course understands that such person must make an independent review of medication information prior to any patient assessment, diagnosis, treatment and/or health management. Any discussion of off-label use of any medication, device, or procedure is informational only and such uses are not endorsed hereby. Nothing contained in this course represents the opinions, views, judgments, or conclusions of RxCe.com LLC. RxCe.com LLC is not liable or responsible to any person for any inaccuracy, error, or omission with respect to this course, or course material.

Computer Hardware/Software Requirements

Please ensure the device you plan to use meets these requirements and specifications:

  • Operating System: Windows 7,8,10, or 11 /Mac OS X 10.9 or later/iOS/Android
  • Supported Browsers: Microsoft Edge, Firefox, Google Chrome, Safari, Opera
  • A connection to the internet
  • For Live Webinars or Conferences: GoToWebinar application for iOS, Android, Mac, or PC. You cannot 'call into' a live conference.

  • Target Audience: Pharmacy Tech
  • Contact Hours: 1.0 (0.1 CEUs)
  • Activity Release Date: 3/18/2024
  • Activity Expiration Date: 3/18/2027
  • Activity Type: Knowledge
  • UAN: 0669-0000-24-033-H01-T
  • Topic: Disease State Management/Drug Therapy
  • CeBroker Number: 20-1186326

Author:

L. Austin Fredrickson, MD, FACP

AUTHOR BIO

VIEW VIDEO

The logo for the Accreditation Council for Pharmacy Education (ACPE).

RxCe.com, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

The logo for the Pharmacy Technician Certification Board (PTCB).
PTCB Course Recognition

RxCe.com, LLC, offers pharmacy technician continuing education courses for PTCB recertification. Pharmacy technician courses are indicated both in the Target Audience description and the ACPE UAN which will end with a "T".

‹‹ Back to Course List